31
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Olanzapine use in acute porphyria

&
Pages 67-69 | Published online: 12 Jul 2009

REFERENCES

  • Crimlisk HL (1997) The little imitator — porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 62: 319–28.
  • McColl KEL, Dover S, Fitzsimons E, Moore MR (1996) Porphyrin metabolism and the porphyrias. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds) Oxford textbook of medicine, 3rd edition. Oxford: Oxford University Press: 1388—99.
  • Lishman WA (1998) Endocrine diseases and metabolic disorders. In: Organic psychiatry: the psychological consequences of cerebral disorder, 3rd edition. London: Blackwell Science: 567—9.
  • Anonymous (2001) Acute porphyrias. In: Mehta DK (ed.) British national formulary, Number 41. London: British Medical Association: 459–60.
  • Gorchein A (1997) Drug treatment in acute porphyria. Br J Clin Pharmacol 44: 427–34.
  • Strauss J, DiMartini A (1999) Use of olanzapine in hereditary coproporphyria. Psychosomatics 40: 444–5.
  • Holroyd S, Seward RL (1999) Psychotropic drugs in acute intermittent porphyria. Clin Pharmacol Ther 66: 323–5.
  • Stephenson CME, Pilowsky LS (1999) Psychopharmacology of olanzapine: A review. Br J Psychiatry 174(suppl. 38): 52—8.
  • Anonymous (2001) Acute porphyrias. In: Mehta DK (eds) British national formulary, Number 41. London: British Medical Association: 174, 636.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.